Products

alpha 1 Antichymotrypsin / AACT antibody

Synonyms:A1 Antichymotrypsin antibody, AACT antibody, ACT antibody, Alpha 1 antichymotrypsin antibody, GIG24 antibody, GIG25 antibody, Serpin A3 antibody, SERPINA3 antibody
Catalogue No.:FNab00317Reativity:Human, Mouse, Rat
Host:RabbitTested Application:ELISA, IHC, WB, IF
Clonality:polyclonalIsotype:IgG
  • SPECIFICATIONS
Product Name
alpha 1 Antichymotrypsin / AACT antibody
Catalogue No.
FNab00317
Size
100μg
Form
liquid
Purification
Immunogen affinity purified
Purity
≥95% as determined by SDS-PAGE
Clonality
polyclonal
Isotype
IgG
Storage
PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months (Avoid repeated freeze / thaw cycles.)
Immunogen
Immunogen
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3
Alternative Names
A1 Antichymotrypsin antibody, AACT antibody, ACT antibody, Alpha 1 antichymotrypsin antibody, GIG24 antibody, GIG25 antibody, Serpin A3 antibody, SERPINA3 antibody
UniProt ID
P01011
Observed MW
50 kDa
Application
Tested Applications
ELISA, IHC, WB, IF
Recommended dilution
WB: 1:500 - 1:2000; IHC: 1:50 - 1:100; IF: 1:50 - 1:200
Validated Images
human blood tissue were subjected to SDS PAGE followed by western blot with FNab00317(SERPINA3, AACT antibody) at dilution of 1:1000
Immunohistochemistry of paraffin-embedded rat brain using FNab00317( SERPINA3, AACT Antibody) at dilution of 1:50
Background
The protein encoded by this gene is a plasma protease inhibitor and member of the serine protease inhibitor class. Polymorphisms in this protein appear to be tissue specific and influence protease targeting. Variations in this protein's sequence have been implicated in Alzheimer's disease, and deficiency of this protein has been associated with liver disease. Mutations have been identified in patients with Parkinson disease and chronic obstructive pulmonary disease.